Evidence map›Paper›PMID 40629262›Full record

ArticleBMC ophthalmology2025

Pupillographic evaluation accompanying structural and functional assessment of the optic nerve in patients with Parkinson's disease.

Erdinç Bozkurt, Ersin Muhafız, Can Emre Erdoğan, Şerif Nizamoğulları, Güvenç Toprak, Bayram Meydan

Abstract read
In one paragraph

Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Erdinç BozkurtDepartment of Ophthalmology, The University of Health Sciences, Umraniye Education and Research Hospital, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-5570-799X
Ersin MuhafızDepartment of Ophthalmology, Faculty of Medicine, Kafkas University, Kars, Turkey.ORCID http://orcid.org/0000-0002-8281-8767
Can Emre ErdoğanDepartment of Neurology, Denizli State Hospital, Denizli, Turkey.ORCID http://orcid.org/0000-0003-1228-5181
Şerif NizamoğullarıDepartment of Ophthalmology, Hatay Education and Research Hospital, Hatay, Turkey.ORCID http://orcid.org/0000-0001-8439-4809
Güvenç ToprakDepartment of Ophthalmology, Faculty of Medicine, Düzce University, Düzce, 81620, Turkey.ORCID http://orcid.org/0000-0001-8363-2983
Bayram MeydanDepartment of Ophthalmology, Faculty of Medicine, Düzce University, Düzce, 81620, Turkey. dr.bayrammeydan@gmail.com.ORCID http://orcid.org/0000-0002-7752-6516

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo evaluate static and dynamic pupillary functions, contrast sensitivity, and retinal nerve fiber layer (RNFL) thickness in patients with Parkinson's disease.

methodsThe study included 25 right eyes of patients with Parkinson's disease (mean age: 67.88 ± 9.40 years) and 26 right eyes of age- and sex-matched healthy controls (mean age: 64.15 ± 7.60 years). Following the measurement of visual acuity and intraocular pressure, the RNFL thickness of the right eye was assessed using optical coherence tomography (Optovue, Inc., Fremont, CA, USA), and contrast sensitivity was measured with the CSV-1000E (Vector Vision, Dayton, OH, USA). Following a 5-minute period of dark adaptation, both static and dynamic pupillographic parameters were assessed using the Sirius corneal topography device (Sirius, CSO, Florence, Italy).

resultsThere was no statistically significant difference between the groups in terms of age and sex (p = 0.126 and p = 0.579, respectively). RNFL thickness in the superior, inferior, nasal, and temporal quadrants of the right eye were as follows for Parkinson's and control groups, respectively: 133.6 ± 18.03 vs. 144.73 ± 17.44 μm (p = 0.03), 122.0 ± 14.47 vs. 134.96 ± 25.28 μm (p = 0.031), 67.76 ± 12.05 vs. 74.65 ± 12.05 μm (p = 0.047), and 66.36 ± 8.72 vs. 72.77 ± 14.0 μm (p = 0.057). A statistically significant thinning was observed in all quadrants except the temporal quadrant in Parkinson's patients (Fig. 1). Contrast sensitivity was significantly lower in the Parkinson's group across all spatial frequencies compared to controls (p = 0.03, 0.01, < 0.01, and 0.02, respectively) (Fig. 2). Although pupil sizes were smaller in the Parkinson's group under scotopic, mesopic, and photopic conditions in static pupillography, the differences were not statistically significant (p > 0.05). Similarly, in dynamic pupillography, the pupil diameters at 0, 2, 4, 8, 12, and 16 s were smaller in the Parkinson's group, but no statistically significant differences were found between the groups (p > 0.05) (Fig. 3).

conclusionsWhile a significant reduction in RNFL thickness and contrast sensitivity was observed in patients with Parkinson's disease, static and dynamic pupillographic parameters did not differ significantly between the groups. Therefore, the prognostic utility of pupillography in Parkinson's disease remains inconclusive and should be further investigated in larger and longitudinal studies.

Indexed as

Optic NerveParkinson DiseasePupilRetinal Ganglion CellsAgedContrast SensitivityFemaleHumansIntraocular PressureMaleMiddle AgedNerve FibersTomography, Optical CoherenceVisual AcuityContrast sensitivityNeurodegenerationParkinson’s diseasePupillographyRNFLVisual function

Identifiers

PMID40629262
PMCPMC12235834

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.